Large Volume Parenteral (LVP) Industry Research Report 2023

Large Volume Parenteral (LVP) Industry Research Report 2023


Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

Highlights

The global Large Volume Parenteral (LVP) market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Large Volume Parenteral (LVP), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Parenteral (LVP).
The Large Volume Parenteral (LVP) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Large Volume Parenteral (LVP) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Parenteral (LVP) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs

Product Type Insights

Global markets are presented by Large Volume Parenteral (LVP) type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Large Volume Parenteral (LVP) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Large Volume Parenteral (LVP) segment by Type

Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Large Volume Parenteral (LVP) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Large Volume Parenteral (LVP) market.
Large Volume Parenteral (LVP) segment by Application

Basic Infusion
Therapeutic Infusion
Nutritious Infusion

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Large Volume Parenteral (LVP) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Parenteral (LVP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Large Volume Parenteral (LVP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Large Volume Parenteral (LVP) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Parenteral (LVP).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Large Volume Parenteral (LVP) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Large Volume Parenteral (LVP) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Large Volume Parenteral (LVP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Large Volume Parenteral (LVP) Market Size (2018-2029) & (US$ Million)
2.2.2 Global Large Volume Parenteral (LVP) Sales (2018-2029)
2.2.3 Global Large Volume Parenteral (LVP) Market Average Price (2018-2029)
2.3 Large Volume Parenteral (LVP) by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
2.4 Large Volume Parenteral (LVP) by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Basic Infusion
2.4.3 Therapeutic Infusion
2.4.4 Nutritious Infusion
3 Market Competitive Landscape by Manufacturers
3.1 Global Large Volume Parenteral (LVP) Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Large Volume Parenteral (LVP) Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Large Volume Parenteral (LVP) Revenue of Manufacturers (2018-2023)
3.4 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2018-2023)
3.5 Global Large Volume Parenteral (LVP) Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
3.8 Global Manufacturers of Large Volume Parenteral (LVP), Date of Enter into This Industry
3.9 Global Large Volume Parenteral (LVP) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Baxter Healthcare
4.1.1 Baxter Healthcare Company Information
4.1.2 Baxter Healthcare Business Overview
4.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
4.1.5 Baxter Healthcare Recent Developments
4.2 Kelun Pharma
4.2.1 Kelun Pharma Company Information
4.2.2 Kelun Pharma Business Overview
4.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
4.2.5 Kelun Pharma Recent Developments
4.3 B. Braun
4.3.1 B. Braun Company Information
4.3.2 B. Braun Business Overview
4.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.3.4 B. Braun Large Volume Parenteral (LVP) Product Portfolio
4.3.5 B. Braun Recent Developments
4.4 Fresenius
4.4.1 Fresenius Company Information
4.4.2 Fresenius Business Overview
4.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Fresenius Large Volume Parenteral (LVP) Product Portfolio
4.4.5 Fresenius Recent Developments
4.5 Teva Pharmaceutical Industries
4.5.1 Teva Pharmaceutical Industries Company Information
4.5.2 Teva Pharmaceutical Industries Business Overview
4.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments
4.6 Pfizer (Hospira)
4.6.1 Pfizer (Hospira) Company Information
4.6.2 Pfizer (Hospira) Business Overview
4.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
4.6.5 Pfizer (Hospira) Recent Developments
4.7 Ostuka Pharmaceutical
4.7.1 Ostuka Pharmaceutical Company Information
4.7.2 Ostuka Pharmaceutical Business Overview
4.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
4.7.5 Ostuka Pharmaceutical Recent Developments
6.8 CR Double-Crane
4.8.1 CR Double-Crane Company Information
4.8.2 CR Double-Crane Business Overview
4.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.8.4 CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
4.8.5 CR Double-Crane Recent Developments
4.9 Pisa
4.9.1 Pisa Company Information
4.9.2 Pisa Business Overview
4.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Pisa Large Volume Parenteral (LVP) Product Portfolio
4.9.5 Pisa Recent Developments
4.10 Huaren
4.10.1 Huaren Company Information
4.10.2 Huaren Business Overview
4.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Huaren Large Volume Parenteral (LVP) Product Portfolio
4.10.5 Huaren Recent Developments
6.11 Patheon
6.11.1 Patheon Company Information
6.11.2 Patheon Large Volume Parenteral (LVP) Business Overview
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Patheon Large Volume Parenteral (LVP) Product Portfolio
6.11.5 Patheon Recent Developments
6.12 Beximco Pharma
6.12.1 Beximco Pharma Company Information
6.12.2 Beximco Pharma Large Volume Parenteral (LVP) Business Overview
6.12.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
6.12.5 Beximco Pharma Recent Developments
6.13 Albert David
6.13.1 Albert David Company Information
6.13.2 Albert David Large Volume Parenteral (LVP) Business Overview
6.13.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Albert David Large Volume Parenteral (LVP) Product Portfolio
6.13.5 Albert David Recent Developments
6.14 PSI Ltd
6.14.1 PSI Ltd Company Information
6.14.2 PSI Ltd Large Volume Parenteral (LVP) Business Overview
6.14.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.14.4 PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
6.14.5 PSI Ltd Recent Developments
6.15 Ozon Pharmaceuticals
6.15.1 Ozon Pharmaceuticals Company Information
6.15.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Business Overview
6.15.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
6.15.5 Ozon Pharmaceuticals Recent Developments
6.16 BAG Healthcare
6.16.1 BAG Healthcare Company Information
6.16.2 BAG Healthcare Large Volume Parenteral (LVP) Business Overview
6.16.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.16.4 BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
6.16.5 BAG Healthcare Recent Developments
6.17 BML Parenteral Drugs
6.17.1 BML Parenteral Drugs Company Information
6.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Business Overview
6.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2018-2023)
6.17.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
6.17.5 BML Parenteral Drugs Recent Developments
5 Global Large Volume Parenteral (LVP) Market Scenario by Region
5.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Large Volume Parenteral (LVP) Sales by Region: 2018-2029
5.2.1 Global Large Volume Parenteral (LVP) Sales by Region: 2018-2023
5.2.2 Global Large Volume Parenteral (LVP) Sales by Region: 2024-2029
5.3 Global Large Volume Parenteral (LVP) Revenue by Region: 2018-2029
5.3.1 Global Large Volume Parenteral (LVP) Revenue by Region: 2018-2023
5.3.2 Global Large Volume Parenteral (LVP) Revenue by Region: 2024-2029
5.4 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.4.1 North America Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.4.3 North America Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.5.1 Europe Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.5.3 Europe Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.6.1 Asia Pacific Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.6.3 Asia Pacific Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.7.1 Latin America Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.7.3 Latin America Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
5.8.1 Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2018-2029)
5.8.3 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029)
6.1.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029) & (M Units)
6.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2018-2029)
6.2 Global Large Volume Parenteral (LVP) Revenue by Type (2018-2029)
6.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2018-2029)
6.3 Global Large Volume Parenteral (LVP) Price by Type (2018-2029)
7 Segment by Application
7.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029)
7.1.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029) & (M Units)
7.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2018-2029)
7.2 Global Large Volume Parenteral (LVP) Revenue by Application (2018-2029)
6.2.1 Global Large Volume Parenteral (LVP) Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2018-2029)
7.3 Global Large Volume Parenteral (LVP) Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Large Volume Parenteral (LVP) Value Chain Analysis
8.1.1 Large Volume Parenteral (LVP) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Large Volume Parenteral (LVP) Production Mode & Process
8.2 Large Volume Parenteral (LVP) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Large Volume Parenteral (LVP) Distributors
8.2.3 Large Volume Parenteral (LVP) Customers
9 Global Large Volume Parenteral (LVP) Analyzing Market Dynamics
9.1 Large Volume Parenteral (LVP) Industry Trends
9.2 Large Volume Parenteral (LVP) Industry Drivers
9.3 Large Volume Parenteral (LVP) Industry Opportunities and Challenges
9.4 Large Volume Parenteral (LVP) Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Large Volume Parenteral (LVP) Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Large Volume Parenteral (LVP) Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Large Volume Parenteral (LVP) Revenue of Manufacturers (2018-2023)
Table 9. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Large Volume Parenteral (LVP) Average Price (US$/K Units) of Manufacturers (2018-2023)
Table 11. Global Large Volume Parenteral (LVP) Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Large Volume Parenteral (LVP), Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Large Volume Parenteral (LVP) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Baxter Healthcare Company Information
Table 17. Baxter Healthcare Business Overview
Table 18. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 19. Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolio
Table 20. Baxter Healthcare Recent Developments
Table 21. Kelun Pharma Company Information
Table 22. Kelun Pharma Business Overview
Table 23. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 24. Kelun Pharma Large Volume Parenteral (LVP) Product Portfolio
Table 25. Kelun Pharma Recent Developments
Table 26. B. Braun Company Information
Table 27. B. Braun Business Overview
Table 28. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 29. B. Braun Large Volume Parenteral (LVP) Product Portfolio
Table 30. B. Braun Recent Developments
Table 31. Fresenius Company Information
Table 32. Fresenius Business Overview
Table 33. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 34. Fresenius Large Volume Parenteral (LVP) Product Portfolio
Table 35. Fresenius Recent Developments
Table 36. Teva Pharmaceutical Industries Company Information
Table 37. Teva Pharmaceutical Industries Business Overview
Table 38. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 39. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Product Portfolio
Table 40. Teva Pharmaceutical Industries Recent Developments
Table 41. Pfizer (Hospira) Company Information
Table 42. Pfizer (Hospira) Business Overview
Table 43. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 44. Pfizer (Hospira) Large Volume Parenteral (LVP) Product Portfolio
Table 45. Pfizer (Hospira) Recent Developments
Table 46. Ostuka Pharmaceutical Company Information
Table 47. Ostuka Pharmaceutical Business Overview
Table 48. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 49. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolio
Table 50. Ostuka Pharmaceutical Recent Developments
Table 51. CR Double-Crane Company Information
Table 52. CR Double-Crane Business Overview
Table 53. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 54. CR Double-Crane Large Volume Parenteral (LVP) Product Portfolio
Table 55. CR Double-Crane Recent Developments
Table 56. Pisa Company Information
Table 57. Pisa Business Overview
Table 58. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 59. Pisa Large Volume Parenteral (LVP) Product Portfolio
Table 60. Pisa Recent Developments
Table 61. Huaren Company Information
Table 62. Huaren Business Overview
Table 63. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 64. Huaren Large Volume Parenteral (LVP) Product Portfolio
Table 65. Huaren Recent Developments
Table 66. Patheon Company Information
Table 67. Patheon Business Overview
Table 68. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 69. Patheon Large Volume Parenteral (LVP) Product Portfolio
Table 70. Patheon Recent Developments
Table 71. Beximco Pharma Company Information
Table 72. Beximco Pharma Business Overview
Table 73. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 74. Beximco Pharma Large Volume Parenteral (LVP) Product Portfolio
Table 75. Beximco Pharma Recent Developments
Table 76. Albert David Company Information
Table 77. Albert David Business Overview
Table 78. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 79. Albert David Large Volume Parenteral (LVP) Product Portfolio
Table 80. Albert David Recent Developments
Table 81. PSI Ltd Company Information
Table 82. PSI Ltd Business Overview
Table 83. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 84. PSI Ltd Large Volume Parenteral (LVP) Product Portfolio
Table 85. PSI Ltd Recent Developments
Table 86. Ozon Pharmaceuticals Company Information
Table 87. Ozon Pharmaceuticals Business Overview
Table 88. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 89. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolio
Table 90. Ozon Pharmaceuticals Recent Developments
Table 91. BAG Healthcare Company Information
Table 92. BAG Healthcare Business Overview
Table 93. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 94. BAG Healthcare Large Volume Parenteral (LVP) Product Portfolio
Table 95. BAG Healthcare Recent Developments
Table 96. BML Parenteral Drugs Company Information
Table 97. BML Parenteral Drugs Business Overview
Table 98. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 99. BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolio
Table 100. BML Parenteral Drugs Recent Developments
Table 101. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 102. Global Large Volume Parenteral (LVP) Sales by Region (2018-2023) & (M Units)
Table 103. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2018-2023)
Table 104. Global Large Volume Parenteral (LVP) Sales by Region (2024-2029) & (M Units)
Table 105. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2024-2029)
Table 106. Global Large Volume Parenteral (LVP) Revenue by Region (2018-2023) & (US$ Million)
Table 107. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2018-2023)
Table 108. Global Large Volume Parenteral (LVP) Revenue by Region (2024-2029) & (US$ Million)
Table 109. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2024-2029)
Table 110. North America Large Volume Parenteral (LVP) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. North America Large Volume Parenteral (LVP) Sales by Country (2018-2023) & (M Units)
Table 112. North America Large Volume Parenteral (LVP) Sales by Country (2024-2029) & (M Units)
Table 113. North America Large Volume Parenteral (LVP) Revenue by Country (2018-2023) & (US$ Million)
Table 114. North America Large Volume Parenteral (LVP) Revenue by Country (2024-2029) & (US$ Million)
Table 115. Europe Large Volume Parenteral (LVP) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Europe Large Volume Parenteral (LVP) Sales by Country (2018-2023) & (M Units)
Table 117. Europe Large Volume Parenteral (LVP) Sales by Country (2024-2029) & (M Units)
Table 118. Europe Large Volume Parenteral (LVP) Revenue by Country (2018-2023) & (US$ Million)
Table 119. Europe Large Volume Parenteral (LVP) Revenue by Country (2024-2029) & (US$ Million)
Table 120. Asia Pacific Large Volume Parenteral (LVP) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2018-2023) & (M Units)
Table 122. Asia Pacific Large Volume Parenteral (LVP) Sales by Country (2024-2029) & (M Units)
Table 123. Asia Pacific Large Volume Parenteral (LVP) Revenue by Country (2018-2023) & (US$ Million)
Table 124. Asia Pacific Large Volume Parenteral (LVP) Revenue by Country (2024-2029) & (US$ Million)
Table 125. Latin America Large Volume Parenteral (LVP) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 126. Latin America Large Volume Parenteral (LVP) Sales by Country (2018-2023) & (M Units)
Table 127. Latin America Large Volume Parenteral (LVP) Sales by Country (2024-2029) & (M Units)
Table 128. Latin America Large Volume Parenteral (LVP) Revenue by Country (2018-2023) & (US$ Million)
Table 129. Latin America Large Volume Parenteral (LVP) Revenue by Country (2024-2029) & (US$ Million)
Table 130. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2018-2023) & (M Units)
Table 132. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2024-2029) & (M Units)
Table 133. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2018-2023) & (US$ Million)
Table 134. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2024-2029) & (US$ Million)
Table 135. Global Large Volume Parenteral (LVP) Sales by Type (2018-2023) & (M Units)
Table 136. Global Large Volume Parenteral (LVP) Sales by Type (2024-2029) & (M Units)
Table 137. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2018-2023)
Table 138. Global Large Volume Parenteral (LVP) Sales Market Share by Type (2024-2029)
Table 139. Global Large Volume Parenteral (LVP) Revenue by Type (2018-2023) & (US$ Million)
Table 140. Global Large Volume Parenteral (LVP) Revenue by Type (2024-2029) & (US$ Million)
Table 141. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2018-2023)
Table 142. Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2024-2029)
Table 143. Global Large Volume Parenteral (LVP) Price by Type (2018-2023) & (US$/K Units)
Table 144. Global Large Volume Parenteral (LVP) Price by Type (2024-2029) & (US$/K Units)
Table 145. Global Large Volume Parenteral (LVP) Sales by Application (2018-2023) & (M Units)
Table 146. Global Large Volume Parenteral (LVP) Sales by Application (2024-2029) & (M Units)
Table 147. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2018-2023)
Table 148. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2024-2029)
Table 149. Global Large Volume Parenteral (LVP) Revenue by Application (2018-2023) & (US$ Million)
Table 150. Global Large Volume Parenteral (LVP) Revenue by Application (2024-2029) & (US$ Million)
Table 151. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2018-2023)
Table 152. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2024-2029)
Table 153. Global Large Volume Parenteral (LVP) Price by Application (2018-2023) & (US$/K Units)
Table 154. Global Large Volume Parenteral (LVP) Price by Application (2024-2029) & (US$/K Units)
Table 155. Key Raw Materials
Table 156. Raw Materials Key Suppliers
Table 157. Large Volume Parenteral (LVP) Distributors List
Table 158. Large Volume Parenteral (LVP) Customers List
Table 159. Large Volume Parenteral (LVP) Industry Trends
Table 160. Large Volume Parenteral (LVP) Industry Drivers
Table 161. Large Volume Parenteral (LVP) Industry Restraints
Table 162. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Large Volume Parenteral (LVP)Product Picture
Figure 5. Global Large Volume Parenteral (LVP) Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Large Volume Parenteral (LVP) Market Size (2018-2029) & (US$ Million)
Figure 7. Global Large Volume Parenteral (LVP) Sales (2018-2029) & (M Units)
Figure 8. Global Large Volume Parenteral (LVP) Average Price (US$/K Units) & (2018-2029)
Figure 9. Soft Bag LVP Product Picture
Figure 10. Plastic Bottle LVP Product Picture
Figure 11. Glass Bottle LVP Product Picture
Figure 12. Basic Infusion Product Picture
Figure 13. Therapeutic Infusion Product Picture
Figure 14. Nutritious Infusion Product Picture
Figure 15. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2022
Figure 16. Global Manufacturers of Large Volume Parenteral (LVP), Manufacturing Sites & Headquarters
Figure 17. Global Manufacturers of Large Volume Parenteral (LVP), Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Large Volume Parenteral (LVP) Players Market Share by Revenue in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Large Volume Parenteral (LVP) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. Global Large Volume Parenteral (LVP) Sales by Region in 2022
Figure 22. Global Large Volume Parenteral (LVP) Revenue by Region in 2022
Figure 23. North America Large Volume Parenteral (LVP) Market Size by Country in 2022
Figure 24. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2018-2029)
Figure 25. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Large Volume Parenteral (LVP) Market Size by Country in 2022
Figure 29. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2018-2029)
Figure 30. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2018-2029)
Figure 31. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Large Volume Parenteral (LVP) Market Size by Country in 2022
Figure 37. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Country (2018-2029)
Figure 38. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Country (2018-2029)
Figure 39. China Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. China Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Large Volume Parenteral (LVP) Market Size by Country in 2022
Figure 49. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2018-2029)
Figure 50. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Large Volume Parenteral (LVP) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East and Africa Large Volume Parenteral (LVP) Market Size by Country in 2022
Figure 55. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2018-2029)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings